Donald Maxwell Parkin, MD

African Cancer Registry Network, INCTR, Prama House, 267 Banbury Road, Oxford OX2 7HT, United Kingdom;
Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.

Graduated in medicine from Edinburgh University in 1968. After initial specialisation in internal medicine/gastoenterology, transferred to public health/epidemiology in 1973. After working in UK, mainly in health service information and planning, moved in 1981 to the International Agency for Research on Cancer (WHO) in Lyon, France, as head of the Descriptive Epidemiology Unit, until October 2004.

Currently, his activities are:
Visiting senior research fellow, Clinical Trials Service Unit and Epidemiological Studies Unit, Oxford University, UK1. Most academic activities relate to studies in Africa, initiated as part of the work of the Africa Cancer Registry Network (AFCRN – qv). In addition, engaged in teaching epidemiology to post graduate students, and acting as supervisor to PhD students in Oxford and Khon Kaen (Thailand).
Head of Cancer Prevention Programme, International Network for Cancer treatment and Research (INCTR)3. The main activity since 2011 has been the establishment of the African Cancer Registry Network (AFCRN (www.afcrn.org)), a consortium of population based registries providing a regional hub for the development and improvement of cancer statistics in sub Saharan Africa.
Senior Visiting Scientist, International Agency for Research on Cancer (Lyon). Since September 2012, in order to coordinate the activities of the AFCRN project with the wider goals of the Global Initiative for cancer Registration
Foreign Adjunct Professor, Karolinska Institute

Dr Parkin is a member of the editorial board of several international journals and holds honorary professorships at the Universities of Peking (Beijing) and Tianjin, China. He has published extensively, with more than 400 papers and reviews in the international scientific literature, mainly on descriptive epidemiology (international cancer patterns and trends), with a major concern for cancer registration, and in cancer prevention and control (especially the effectiveness of cancer screening).

Terms of Appointment: June 2018 - June 2020